Are marginalized groups slipping through the cracks when it comes to lung cancer prevention? Pulmonologists looked into this question and will present their conclusions and recommendations in a live-stream Q&A direct from the annual meeting of the American Thoracic Society.
Expert interviews on topics ranging from breaking news, research results, trends, current events, and more.
Newswise is offering reporters a behind-the-scenes look at the state of the research and the impact it might have on global public health by interacting with two leading scientists in the field and an author who has investigated the research for over a decade. With all the elements of a great story, the search for healthful human longevity sheds light on discoveries that could fundamentally reshape human life.
Although most Americans would choose to be healthy if that option were easier, obesity is expected to increase in the coming years, largely due to the negative influence of environmental factors of unhealthy food choices and increasingly sedentary lifestyles. Possible solutions to these issues include an emphasis on education and increased transparency in nutritional information labels for consumers.
Anyone who has ever struggled with poverty knows how extremely expensive it is to be poor. This quote from the African American playwright and novelist, James Baldwin, was recently used by Dr. Jack P. Calareso, President of Anna Maria College, Paxton, MA when discussing the cost of higher education and students of low economic means. Referencing research that identified that 80% of the U.S.’s low income students are forced to enroll in the least selective colleges and universities, Dr. Calareso forces educational leaders, government and elected officials and others to face the facts that poorer students have limited access to more selective institutions.
Howard McLeod, Ph.D., directs the UNC Institute for Pharmacogenomics and Individualized Therapy (IPIT) in the UNC School of Pharmacy. McLeod, Fred Eshelman Distinguished Professor of Pharmacy, has published over 250 peer-reviewed papers on pharmacogenomics, applied therapeutics, or clinical pharmacology and continues to work to integrate genetics principles into clinical practice to advance individualized medicine.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right